Image courtesy of Wikimedia Commons
Sustainability continues to be a hot topic, and the pharmaceutical industry faces pressure to reduce its carbon footprint. As a result, a growing number of pharma companies are stepping up sustainability efforts.
In a growing number of locations, pharma companies are seeing drivers in the regulatory environment to force them to prioritize sustainability. “We’re seeing [pressure] from both regulatory authorities having jurisdiction at the federal, state and local level of different jurisdictions,” said Jeff Wegner, a mechanical engineer at CRB.
A growing number of jurisdictions on the East Coast and West Coast are restricting or banning the use of, for instance, natural gas.
While such restrictions are not yet pervasive, the trend is building, said Wegner, who was among the authors of the Horizons: Life Sciences Report.
Another dimensi…